HF
OGEN icon

HRT Financial’s Oragenics OGEN Stock Holding History

HRT Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,672
Closed -$10K – 5021
2026
Q1 		$10K Buy
+18,672
New +$14.8K ﹤0.01% 3636
2025
Q1 		– Sell
-621
Closed -$6K – 3142
2024
Q4 		$6K Sell
621
-310
-33% -$3.18K ﹤0.01% 2319
2024
Q3 		$10K Buy
+931
New +$26.3K ﹤0.01% 2229
2022
Q4 		– Sell
-7
Closed -$2K – 2940
2022
Q3 		$2K Buy
+7
New +$4.09K ﹤0.01% 2649
2021
Q4 		– Sell
-10
Closed -$10K – 3810
2021
Q3 		$10K Buy
+10
New +$12.1K ﹤0.01% 3189
2020
Q4 		– Sell
-22
Closed -$23K – 2281
2020
Q3 		$23K Buy
+22
New +$35.2K ﹤0.01% 1767

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HRT Financial's OGEN Position: Q2 2026 in Review

HRT Financial sold out of Oragenics (OGEN) in Q2 2026, closing a stake of 18,672 shares — an estimated $10K sold.

HRT Financial first reported a position in OGEN in Q3 2020 and held it in 6 quarters. The position peaked at $23K in Q3 2020. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • HRT Financial reported no remaining Oragenics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 18,672 Oragenics shares in Q2 2026, an estimated $10K.
  • HRT Financial first reported a position in Oragenics in Q3 2020 and held it in 6 quarters.
  • HRT Financial's Oragenics position peaked at $23K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.